Form 13-F position report

DEEP MEDICINE ACQUISITION C

Reported by B Riley Securities Inc

DMAQR CUSIP 243733110 Manager CIK 0001505748

First reported at 47,599 shares this quarter.

New
% of reported 13F value < 0.01% This manager · Q4 2022
Shares 47,599 Quarter-end amount reported
Reported value $2,856 Fair value at quarter end
Consecutive quarters held 1 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2022-12-31 2856

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for DEEP MEDICINE ACQUISITION C held by B Riley Securities Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 New 47,599 +47,599 (0.0%) < 0.01% $2,856 2023-02-07

Who else reported the position

32 managers reported DEEP MEDICINE ACQUISITION C for Q4 2022.

Managers reporting DEEP MEDICINE ACQUISITION C in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
COWEN AND COMPANY LLC Added 2,202,668 +14,517 0.01% $132,160 5 qtrs
MANGROVE PARTNERS Unchanged 1,500,000 0 < 0.01% $90,000 5 qtrs
Yakira Capital Management Inc Unchanged 750,000 0 < 0.01% $45,000 5 qtrs
Owl Creek Asset Management L P Unchanged 750,000 0 < 0.01% $45,000 5 qtrs
Shaolin Capital Management LLC Unchanged 506,323 0 < 0.01% $30,000 5 qtrs
CLEAR STREET LLC Unchanged 377,501 0 < 0.01% $23,000 2 qtrs
K2 PRINCIPAL FUND L P Reduced 355,190 -119,810 < 0.01% $21,311 5 qtrs
AQR Arbitrage LLC Unchanged 375,000 0 < 0.01% $18,750 5 qtrs
WOLVERINE ASSET MANAGEMENT LLC Reduced 257,000 -1,000 < 0.01% $15,420 5 qtrs
WHITEBOX ADVISORS LLC Unchanged 250,000 0 < 0.01% $15,000 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 07, 2023
Filing type
13F-HR
Position type
RIGHT 09/30/2028

Voting authority reported

Sole
47,599
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.